JP2002316936A - Antibacterial agent and anti-inflammatory agent - Google Patents
Antibacterial agent and anti-inflammatory agentInfo
- Publication number
- JP2002316936A JP2002316936A JP2001118498A JP2001118498A JP2002316936A JP 2002316936 A JP2002316936 A JP 2002316936A JP 2001118498 A JP2001118498 A JP 2001118498A JP 2001118498 A JP2001118498 A JP 2001118498A JP 2002316936 A JP2002316936 A JP 2002316936A
- Authority
- JP
- Japan
- Prior art keywords
- gentiana
- nomenclature
- agent
- extract
- hercampuri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、特定の植物の抽出
物を配合することにより、黄色ブドウ球菌、アクネ菌、
溶血レンサ球菌などへの抗菌性に優れた抗菌剤、及びア
トピー性皮膚炎、ニキビ等による皮膚炎症に対して優れ
た抗炎症剤に関する。[0001] The present invention relates to a method for preparing Staphylococcus aureus, Acne,
The present invention relates to an antibacterial agent excellent in antibacterial properties against hemolytic streptococci and the like, and an antiinflammatory agent excellent in skin inflammation due to atopic dermatitis and acne.
【0002】[0002]
【従来の技術】黄色ブドウ球菌は、様々な皮膚疾患と密
接に関わっていることが知られている。例えば、アトピ
ー性皮膚炎においては、掻破によって損傷した皮膚に、
本菌が二次汚染することによって、炎症を引き起こすと
考えられている。黄色ブドウ球菌に対する抗菌剤として
は、臨床分野においては抗生物質が使用されるが、耐性
菌(MRSA)の発現など、問題も多い。また、アクネ
菌はニキビと密接に関わっており、溶血レンサ球菌等は
感染症を引き起こす。2. Description of the Related Art Staphylococcus aureus is known to be closely related to various skin diseases. For example, in atopic dermatitis, the skin damaged by scratching
It is thought that this bacteria causes inflammation by secondary contamination. As an antibacterial agent against Staphylococcus aureus, an antibiotic is used in the clinical field, but there are many problems such as expression of resistant bacteria (MRSA). Acne is closely related to acne, and hemolytic streptococci cause infection.
【0003】[0003]
【発明が解決しようとする課題】かかる状況に鑑み、こ
の発明の課題は黄色ブドウ球菌、アクネ菌、溶血レンサ
球菌等に対する優れた抗菌性を示す、天然物由来の抗菌
剤を提供することにある。In view of such circumstances, an object of the present invention is to provide an antibacterial agent derived from a natural product, which exhibits excellent antibacterial properties against Staphylococcus aureus, acne bacteria, hemolytic streptococci, and the like. .
【0004】[0004]
【課題を解決するための手段】この様な事情により、本
発明者らは鋭意研究を重ねた結果、ウワマンサマナ、エ
ルカンプリ及びカンシャラグアの抽出物が、黄色ブドウ
球菌、アクネ菌、溶血レンサ球菌等に対する優れた抗菌
性、及び皮膚の炎症に対する優れた改善効果を有してい
ることを見出し、本発明を完成するに至った。Under these circumstances, the present inventors have conducted intensive studies, and as a result, the extract of Uwamansamana, Ercampuri, and Kansaragua has been found to be superior to Staphylococcus aureus, Acne, Hemolytic streptococci and the like. It has been found that the present invention has excellent antibacterial properties and an excellent effect of improving skin inflammation, and has completed the present invention.
【0005】本発明で用いられるウワマンサマナ(Huam
ansamana、学名:Jacaranda copaia)は、ノウゼンカズ
ラ科の高木である。主に中米及び南米北部に分布し、生
薬として広く使用されている。ウワマンサマナの別名と
しては、カローバ・ド・マット、コバジャ等がある。[0005] Huamsamana used in the present invention (Huam
ansamana (scientific name: Jacaranda copaia) is a tall tree of the family Noctuidae. It is mainly distributed in Central America and northern South America and is widely used as a crude drug. Other names for Uwamansamana include Calova de Matt and Kobaja.
【0006】本発明で用いられるエルカンプリ(Hercam
puri、学名:Gentiana prostrata、Gentiana nitida
又はGentiana alborosea)は、リンドウ科の一年草で
ある。主に熱帯アメリカに広く分布し、生薬として広く
使用されている。[0006] Hercampuri (Hercam) used in the present invention
puri, scientific name: Gentiana prostrata, Gentiana nitida
Or Gentiana alborosea) is an annual of the Gentian family. It is widely distributed mainly in tropical America and is widely used as a crude drug.
【0007】本発明で用いられるカンシャラグア(Canc
halagua、学名:Sisyrinchium vaginatum)は、アヤメ
科の多年草である。主に南アメリカに広く分布し、生薬
として広く使用されている。[0007] Cancaragua (Canc) used in the present invention
halagua (scientific name: Sisyrinchium vaginatum) is a perennial plant of the Iridaceae family. It is widely distributed mainly in South America and is widely used as a crude drug.
【0008】本発明で使用するウワマンサマナの抽出物
とは、ウワマンサマナの葉、茎、花、実、種子、根、樹
皮、木部等の植物体の一部又は全体から抽出したもので
ある。好ましくは、葉及び茎から抽出して得られるもの
が良い。[0008] The extract of Uwamansamana used in the present invention is extracted from a part or the whole of a plant such as leaves, stems, flowers, fruits, seeds, roots, bark, and xylem of Uwamansana. Preferably, those obtained by extracting from leaves and stems are good.
【0009】本発明で使用するエルカンプリの抽出物と
は、エルカンプリの葉、茎、花、実、種子、根等の植物
体の一部又は全体から抽出したものである。好ましく
は、地上部の全草から抽出して得られるものが良い。The Hercampuri extract used in the present invention is extracted from a part or the whole of a plant such as Hercampuri leaves, stems, flowers, fruits, seeds and roots. Preferably, those obtained by extracting from the whole plant above the ground are good.
【0010】本発明で使用するカンシャラグアの抽出物
とは、カンシャラグアの葉、茎、花、実、種子、根等の
植物体の一部又は全体から抽出したものである。好まし
くは、地上部の全草から抽出して得られるものが良い。The extract of Kansaragua used in the present invention is extracted from a part or the whole of a plant such as leaves, stems, flowers, fruits, seeds and roots of Kansaragua. Preferably, those obtained by extracting from the whole plant above the ground are good.
【0011】抽出方法は特に限定されず、例えば、加熱
抽出したものであっても良いし、常温抽出したものであ
っても良い。[0011] The extraction method is not particularly limited, and may be, for example, a heat-extracted one or a room-temperature-extracted one.
【0012】抽出する溶媒としては、例えば、水、低級
アルコール類(メタノール、エタノール、1-プロパノー
ル、2-プロパノール、1-ブタノール、2-ブタノール
等)、液状多価アルコール(グリセリン、プロピレング
リコール、1,3-ブチレングリコール等)、ケトン類(ア
セトン、メチルエチルケトン等)、アセトニトリル、エ
ステル類(酢酸エチル、酢酸ブチル等)、炭化水素類
(ヘキサン、ヘプタン、流動パラフィン等)、エーテル
類(エチルエーテル、プロピルエーテル、テトラヒドロ
フラン等)が挙げられる。好ましくは、水、低級アルコ
ール及び液状多価アルコール等の極性溶媒が良く、特に
好ましくは、水、エタノール、プロピレングリコール及
び1,3-ブチレングリコールが良い。これらの溶媒は一種
でも二種以上を混合して用いても良い。Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.) and liquid polyhydric alcohols (glycerin, propylene glycol, 1-butanol). , 3-butylene glycol, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, propyl) Ether, tetrahydrofuran, etc.). Preferred are polar solvents such as water, lower alcohols and liquid polyhydric alcohols, and particularly preferred are water, ethanol, propylene glycol and 1,3-butylene glycol. These solvents may be used alone or in combination of two or more.
【0013】ウワマンサマナ、エルカンプリ及びカンシ
ャラグアの抽出物は、抽出した溶液のまま用いても良
く、必要に応じて、濃縮、希釈、濾過等の処理をして用
いても良い。更には、抽出した溶液を濃縮乾固、噴霧乾
燥、凍結乾燥等の処理を行い、乾燥物として用いても良
い。The extract of Uwamansa mana, Ercampuri and Kansharagua may be used as it is as an extracted solution, or may be used after being subjected to treatment such as concentration, dilution, and filtration as required. Further, the extracted solution may be subjected to a treatment such as concentration and drying, spray drying, and freeze drying to be used as a dried product.
【0014】本発明の抗菌剤には、上記抽出物をそのま
ま使用しても良く、ウワマンサマナ、エルカンプリ及び
カンシャラグアの抽出物の効果を損なわない範囲内で、
通常の抗菌剤に用いられる成分である油脂類、ロウ類、
炭化水素類、脂肪酸類、アルコール類、エステル類、界
面活性剤、金属石鹸、pH調整剤、防腐剤、香料、保湿
剤、粉体、紫外線吸収剤、増粘剤、色素、酸化防止剤、
美白剤、キレート剤等の成分を配合することもできる。In the antibacterial agent of the present invention, the above extract may be used as it is, as long as the effect of the extract of Uwamansamana, Ercampuri and Kansharagua is not impaired.
Oils and fats, waxes, which are components used in normal antibacterial agents,
Hydrocarbons, fatty acids, alcohols, esters, surfactants, metal soaps, pH adjusters, preservatives, fragrances, humectants, powders, ultraviolet absorbers, thickeners, pigments, antioxidants,
Components such as a whitening agent and a chelating agent can be blended.
【0015】本発明の抗菌剤は、化粧品、医薬部外品及
び医薬品のいずれにも用いることができ、その剤型とし
ては、例えば、化粧水、クリーム、乳液、ゲル剤、エア
ゾール剤、エッセンス、パック、洗浄剤、浴用剤、ファ
ンデーション、打粉、口紅、軟膏、パップ剤等の皮膚に
適用されるものが挙げられる。The antibacterial agent of the present invention can be used in any of cosmetics, quasi-drugs and pharmaceuticals. Examples of the dosage form include lotions, creams, emulsions, gels, aerosols, essences, Packs, detergents, bath preparations, foundations, powders, lipsticks, ointments, cataplasms and the like applied to the skin can be mentioned.
【0016】[0016]
【実施例】次に本発明を詳細に説明するため、実施例と
して本発明に用いる抽出物の製造例及び実験例を挙げる
が、本発明はこれに限定されるものではない。EXAMPLES In order to explain the present invention in detail, examples of the production of the extract used in the present invention and experimental examples will be given below, but the present invention is not limited thereto.
【0017】製造例1 ウワマンサマナの熱水抽出物 ウワマンサマナの葉及び茎の乾燥物20gに精製水400gを
加え、95〜100℃で2時間抽出した後、濾過し、その濾
液を濃縮し、凍結乾燥してウワマンサマナの熱水抽出物
を5.0g得た。Production Example 1 Hot water extract of Uwamansamana Purified water (400 g) was added to 20 g of dried leaves and stems of Uwamansamana, extracted at 95-100 ° C for 2 hours, filtered, concentrated, and freeze-dried. As a result, 5.0 g of hot water extract of Uwamansa mana was obtained.
【0018】製造例2 ウワマンサマナの50%エタノー
ル抽出物 ウワマンサマナの葉の乾燥物100gに精製水1.0kg及びエ
タノール1.0kgを加え、常温で7日間抽出した後、濾過
し、その濾液を濃縮乾固して、ウワマンサマナのエタノ
ール抽出物を44g得た。Production Example 2 50% ethanol extract of awamansamana 1.0 kg of purified water and 1.0 kg of ethanol were added to 100 g of dried leaves of awamansamana, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness. Thus, 44 g of ethanol extract of Uwamansamana was obtained.
【0019】製造例3 エルカンプリの熱水抽出物 エルカンプリの全草の乾燥物20gに精製水400gを加え、9
5〜100℃で2時間抽出した後、濾過し、その濾液を濃縮
し、凍結乾燥してエルカンプリの熱水抽出物を5.2g得
た。Production Example 3 Hot water extract of Hercampuri Erycampuri whole plant dry matter of 20g, purified water 400g was added, 9
After extraction at 5-100 ° C for 2 hours, the mixture was filtered, and the filtrate was concentrated and lyophilized to obtain 5.2 g of a hot water extract of Ercampuri.
【0020】製造例4 エルカンプリの50%エタノール
抽出物 エルカンプリの葉及び茎の乾燥物100gに精製水1.0kg及
びエタノール1.0kgを加え、常温で7日間抽出した後、
濾過し、その濾液を濃縮乾固して、エルカンプリのエタ
ノール抽出物を23g得た。Production Example 4 50% Ethanol Extract of Hercampli A 1.0 kg of purified water and 1.0 kg of ethanol were added to 100 g of dried leaves and stems of Hercampuri, and extracted at room temperature for 7 days.
After filtration, the filtrate was concentrated to dryness to obtain 23 g of an ethanol extract of Ercampli.
【0021】製造例5 カンシャラグアの熱水抽出物 カンシャラグアの全草の乾燥物20gに精製水400gを加
え、95〜100℃で2時間抽出した後、濾過し、その濾液
を濃縮し、凍結乾燥してカンシャラグアの熱水抽出物を
3.0g得た。Production Example 5 Hot Water Extract of Kansaragua A 400 g of purified water was added to 20 g of dried whole plant of Kansaragua, extracted at 95-100 ° C for 2 hours, filtered, concentrated, and freeze-dried. Hot water extract of Kansaragua
3.0 g was obtained.
【0022】製造例6 カンシャラグアの50%エタノー
ル抽出物 カンシャラグアの葉及び茎の乾燥物100gに精製水1.0kg
及びエタノール1.0kgを加え、常温で7日間抽出した
後、濾過し、その濾液を濃縮乾固して、カンシャラグア
のエタノール抽出物を12g得た。Production Example 6 50% ethanol extract of Kansaragua A 100 kg of dried leaves and stems of Kansaragua are filled with 1.0 kg of purified water.
Then, 1.0 kg of ethanol and 1.0 kg of ethanol were added, and the mixture was extracted at normal temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 12 g of an ethanol extract of Kansaragua.
【0023】次に、本発明の効果を詳細に説明するた
め、実験例を挙げる。Next, experimental examples will be described in order to explain the effects of the present invention in detail.
【0024】実験例1 抗菌力試験 (方法)黄色ブドウ球菌としては、Staphylococcus aur
eus ATCC 6538 を用い、日本化学療法学会標準法のカン
テン平板希釈法に準じて、下記抽出物の in vitro 抗
菌力を測定した。Experimental Example 1 Antibacterial activity test (Method) Staphylococcus aur
Using the eus ATCC 6538, the in vitro antibacterial activity of the following extracts was measured according to the standard plate dilution method of the Japanese Society of Chemotherapy.
【0025】(1)ウワマンサマナの熱水抽出物(製造
例1) (2)ウワマンサマナの50%エタノール抽出物(製造例
2) (3)エルカンプリの熱水抽出物(製造例3) (4)エルカンプリの50%エタノール抽出物(製造例
4) (5)カンシャラグアの熱水抽出物(製造例5) (6)カンシャラグアの50%エタノール抽出物(製造例
6)(1) Hot water extract of Uwamansamana (Production Example 1) (2) 50% ethanol extract of Uwamansamana (Production Example 2) (3) Hot water extract of Ercampuri (Production Example 3) (4) Ercampuri 50% Ethanol Extract of Kansaragua (5) Hot Water Extract of Kansaragua (Production 5) (6) 50% Ethanol Extract of Kansaragua (Production 6)
【0026】なお、カンテン平板希釈法においては、各
抽出物を 0.5、0.25、0.125及び0.0625 %となるように
培地に加え、最小発育阻止濃度(以下MIC、単位:
%)を求めた。また、培地としてはソイビーン・カゼイ
ン・ダイジェストカンテン培地(栄研化学社製)を用
い、37 ℃にて3日間培養した。In the agar plate dilution method, each extract is added to a medium at a concentration of 0.5, 0.25, 0.125 and 0.0625%, and a minimum growth inhibitory concentration (hereinafter referred to as MIC, unit:
%). In addition, a soybean casein digest agar medium (manufactured by Eiken Chemical Co., Ltd.) was used as a medium, and the cells were cultured at 37 ° C. for 3 days.
【0027】(結果)結果を表1に示す。(Results) The results are shown in Table 1.
【0028】[0028]
【表1】 [Table 1]
【0029】上記の表1から、本発明の抽出物は、黄色
ブドウ球菌に対する優れた抗菌性を有することが明らか
である。From the above Table 1, it is clear that the extract of the present invention has excellent antibacterial properties against Staphylococcus aureus.
【0030】実験例2 使用試験 製造例1、3及び5の1.0%水溶液を用いて、皮膚にア
トピー性皮膚炎様の炎症を有する成人10人(男性5
名、女性5名)を対象に1ヶ月間の使用試験を行った。
使用後、アンケート調査により皮膚炎症の改善について
判定した。その結果、ウワマンサマナ、エルカンプリ及
びカンシャラグアの抽出物を含有することを特徴とする
抗炎症剤は優れた皮膚炎症の改善効果を示した(表
2)。なお、試験期間中皮膚トラブルは一人もなく、安
全性においても問題なかった。EXPERIMENTAL EXAMPLE 2 Use Test Using 1.0% aqueous solutions of Production Examples 1, 3 and 5, 10 adults (5 males) having atopic dermatitis-like inflammation on their skin
And five women) for one month.
After use, it was determined by a questionnaire survey about the improvement of skin inflammation. As a result, the anti-inflammatory agent characterized by containing extracts of Uwamansamana, Hercampuri and Kansharagua showed excellent skin inflammation improving effect (Table 2). There was no skin trouble during the test, and there was no problem in safety.
【0031】[0031]
【表2】 [Table 2]
【0032】[0032]
【発明の効果】以上のことから、本発明のウワマンサマ
ナ、エルカンプリ及びカンシャラグアの抽出物は、黄色
ブドウ球菌等に対する優れた抗菌性を有した。また、ア
トピー性皮膚炎様の皮膚炎症に対して、優れた改善効果
を示した。As described above, the extracts of Uwamansa mana, Hercampuri and Kansharagua of the present invention have excellent antibacterial properties against Staphylococcus aureus and the like. In addition, it exhibited an excellent improvement effect on atopic dermatitis-like skin inflammation.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 小島 肇夫 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 (72)発明者 大隅 和寿 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 (72)発明者 堅田 友則 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 Fターム(参考) 4C088 AB12 AB67 AB72 AC03 AC04 AC05 AC06 BA09 BA10 CA05 CA06 CA11 MA07 ZA89 ZA90 ZB11 ZB13 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Hajio Kojima 2-7 Tomicho, Nishi-ku, Nagoya City Japan Menard Cosmetics Co., Ltd. (72) Inventor Kazutoshi Osumi 2-7 Tomicho, Nishi-ku Nagoya City Japan Menard Cosmetics Co., Ltd. (72) Inventor Tomonori Katata 2-7 Torimicho, Nishi-ku, Nagoya City Menard Co., Ltd. F-term (reference) 4C088 AB12 AB67 AB72 AC03 AC04 AC05 AC06 BA09 BA10 CA05 CA06 CA11 MA07 ZA89 ZA90 ZB11 ZB13
Claims (4)
ンシャラグアから選ばれる一種又は二種以上の抽出物を
含有することを特徴とする抗菌剤。1. An antibacterial agent comprising one or more extracts selected from Uwamansamana, Hercampuri and Kansharagua.
項1記載の抗菌剤。2. The antibacterial agent according to claim 1, which is effective against Staphylococcus aureus.
ールから一種又は二種以上選ばれる溶媒による抽出物で
あることを特徴とする請求項1記載の抗菌剤。3. The antimicrobial agent according to claim 1, wherein the antimicrobial agent is an extract with one or more solvents selected from water, lower alcohols, and liquid polyhydric alcohols.
ンシャラグアから選ばれる一種又は二種以上の抽出物を
含有することを特徴とする抗炎症剤。4. An anti-inflammatory agent comprising one or more extracts selected from Uwamansamana, Ercampuri and Kansharagua.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001118498A JP4799753B2 (en) | 2001-04-17 | 2001-04-17 | Antibacterial and anti-inflammatory agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001118498A JP4799753B2 (en) | 2001-04-17 | 2001-04-17 | Antibacterial and anti-inflammatory agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002316936A true JP2002316936A (en) | 2002-10-31 |
JP4799753B2 JP4799753B2 (en) | 2011-10-26 |
Family
ID=18968879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001118498A Expired - Lifetime JP4799753B2 (en) | 2001-04-17 | 2001-04-17 | Antibacterial and anti-inflammatory agents |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4799753B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05306231A (en) * | 1992-04-24 | 1993-11-19 | Pola Chem Ind Inc | Skin external preparation |
JP2000336024A (en) * | 1999-05-27 | 2000-12-05 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisturizing plat extract |
JP2001106619A (en) * | 1999-10-05 | 2001-04-17 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
-
2001
- 2001-04-17 JP JP2001118498A patent/JP4799753B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05306231A (en) * | 1992-04-24 | 1993-11-19 | Pola Chem Ind Inc | Skin external preparation |
JP2000336024A (en) * | 1999-05-27 | 2000-12-05 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisturizing plat extract |
JP2001106619A (en) * | 1999-10-05 | 2001-04-17 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
JP4799753B2 (en) | 2011-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101393007B1 (en) | Cosmetic Composition for Skin-aging Protection and Wrinkle Improvement Comprising the Extract of Nephelium lappaceum and Litchi chinensis sonn as Active Ingredient | |
KR101549299B1 (en) | Anti-aging and Anti-inflammation and Anti-oxidation cosmetic composition including Lotus Plant Placenta Cell Cultures Extracts | |
KR101533947B1 (en) | Anti-aging and Anti-inflammation and Anti-oxidation cosmetic composition including Paeonia suffruticosa Plant Placenta Cell Cultures Extracts | |
KR102286991B1 (en) | Cosmetic composition for regulating microbe in skin comprising extract of zanthoxylum piperitum fruit or fractions from thereof | |
KR101561408B1 (en) | Anti-aging and Anti-inflammation and Anti-oxidation cosmetic composition including Peony Plant Placenta Cell Cultures Extracts | |
KR100816261B1 (en) | A cosmetic composition for improving skin wrinkle comprising the extract of magnolia sieboldii as active ingredient | |
KR101533213B1 (en) | Anti-aging and Anti-inflammation and Anti-oxidation cosmetic composition including Anemone Plant Placenta Cell Cultures Extracts | |
US4880630A (en) | Skin care compositions having keratolytic and antiinflammatory activity | |
KR102002997B1 (en) | Cosmetic composition including taxifolin glucosides and extracting method of paeonia lactiflora extracts | |
KR102290424B1 (en) | Cosmetic composition for regulating microbe in skin comprising extract of rosa multiflora thunberg fruit or fractions from thereof | |
JP5562616B2 (en) | Semaphorin expression enhancer | |
JP2002316936A (en) | Antibacterial agent and anti-inflammatory agent | |
KR100451885B1 (en) | Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate | |
KR20040087644A (en) | Cosmetic Composition Comprising Pyrus communis L. Extract for Skin Whitening | |
JP2002029992A (en) | Activity accelerator for active oxygen scavenging enzyme | |
KR100855456B1 (en) | Cosmetic composition for pore-minimizing containing extract of epimedium koreanum as active ingredient | |
JP4953621B2 (en) | Hair restorer | |
KR101323781B1 (en) | Cosmetic composition containing antibiotics isolated from the Alpinia galanga (L.) Sw | |
JP3217741B2 (en) | Whitening agent | |
JPH10298095A (en) | Antibacterial agent | |
KR102331903B1 (en) | Cosmetic Composition comprising Spergularia marina Extract | |
JP2003081747A5 (en) | ||
KR102360754B1 (en) | Cosmetic composition for regulating microbe in skin comprising extract of betula platyphylla or fractions from thereof | |
KR102282645B1 (en) | Cosmetic composition comprising mixed extracts of cnidium officinale and scutellaria baicalensis or compounds seperated from thereof for alleiviating acne and dandruff | |
JP5946698B2 (en) | Whitening agent and skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110628 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110709 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110802 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110803 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140812 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4799753 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |